Thalidomide capsules

The mechanism of action of this product is speculated to be immunosuppressive and immunomodulatory. It can stabilize the lysosomal membrane, inhibit the chemotaxis of neutrophils, and produce anti-inflammatory effects. It also has anti-prostaglandin, histamine and 5-hydroxytryptamine effects. The mechanism of action of this product is speculated to be immunosuppressive and immunomodulatory. It can stabilize the lysosomal membrane, inhibit the chemotaxis of neutrophils, and produce anti-inflammatory effects. It also has anti-prostaglandin, histamine and 5-hydroxytryptamine effects.

The content of this product is white or off-white granules or powder.

Dermatological medicine. Used to control lepromatous leprosy reactions.

Oral administration: 25-50 mg (1-2 tablets) at a time, 100-200 mg (4-8 tablets) per day, or as directed by a doctor.

1. Gastrointestinal discomfort such as dry mouth, nausea, vomiting and abdominal pain. 2. Dizziness, headache, drowsiness, rash and facial edema. 3. It can cause teratogenesis and is contraindicated for pregnant women. Non-leprosy patients should not use this drug.

1. Pregnant and lactating women are prohibited from using this product. 2. Children are prohibited from using this product. 3. People who are allergic to this product are prohibited from using this product. 4. Drivers and machine operators are prohibited from using this product.

Precautions for children: Not for use in children. Precautions for pregnancy and lactation: Not for use in pregnant and lactating women. Precautions for the elderly: Not yet clear.

If used with other drugs, interactions may occur. Please consult your doctor or pharmacist for details.

seal.

25mg

24 months

Suzhou Changzheng-xinkai Pharmaceutical Co., Ltd.

• Founded in:

  2000-04-27

• Address:

  No. 567, Liufeng Road, Hedong Industrial Park, Wuzhong Economic Development Zone, Suzhou

• Tax NO.:

  91320500720535900Q

• Registered Funds:

  38.526778 million yuan

• Email:

  Log in to view